Brief: Portage Biotech Announces First Patient Dosed In Phase 1A Trial Of PORT-6 In Select Solid Tumors
26/06/2023 13:20
June 26 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH ANNOUNCES FIRST PATIENT DOSED IN PHASE 1A
TRIAL
OF PORT-6 IN SELECT SOLID TUMORS
Source text for Eikon: ID:nGNX9pGXyK
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsAlpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
Brief: Alpha Compute Signs Binding Gpu Contract, Leasing ALPHA-03 Cluster Under Four-Year, $81.7 Million Agreement In Its Missouri Superintelligence Factory
Alpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview